Rare diseases
Investigational molecules
Locations
Study Comparing Enfortumab Vedotin and Pembrolizumab with Chemotherapy for Patients with Muscle-Invasive Bladder Cancer
SpainStudy of Adagrasib Dosing in Patients with Previously Treated Non-Small Cell Lung Cancer with KRAS G12C Mutation
SpainStudy of Acalabrutinib, Venetoclax, and Rituximab for Patients with Newly Diagnosed Mantle Cell Lymphoma
SpainStudy on the Effectiveness and Safety of MK-0616 for Adults with High Cholesterol
SpainStudy of Sacituzumab Govitecan for Patients with Advanced or Metastatic Bladder Cancer
SpainStudy Comparing Repotrectinib and Crizotinib for Patients with Advanced or Metastatic ROS1-positive Non-Small Cell Lung Cancer
SpainStudy on the Effects of AZD0780 on Cholesterol Levels in Adults Aged 18-75 with Dyslipidemia
SpainStudy Comparing SB27 and Pembrolizumab for Patients with Metastatic Non-Small Cell Lung Cancer
SpainStudy of Patritumab Deruxtecan with or without Endocrine Therapy for High-Risk HR+/HER2- Early Breast Cancer in Untreated Patients
SpainStudy of Giredestrant Combined with Pertuzumab-Trastuzumab (Phesgo) for Patients with Previously Untreated HER2-Positive, Estrogen Receptor-Positive Locally Advanced or Metastatic Breast Cancer
SpainStudy of CGT9486 and Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumors
SpainLong-Term Study on the Safety of Avalotcagene Ontaparvovec for Adults with Late-Onset Ornithine Transcarbamylase Deficiency
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
